How to Buy Crizotinib from India

Description

Crizotinib for ALK-Positive Lung Cancer: What Patients Worldwide Need to Know

Crizotinib is a targeted therapy prescribed for patients diagnosed with non-small cell lung cancer (NSCLC) that tests positive for ALK (anaplastic lymphoma kinase) or ROS1 gene rearrangements.

For patients facing the significant financial burden of long-term cancer treatment particularly those in the United States, United Kingdom, or the Middle East who are uninsured, underinsured, or live in countries without public subsidy for specialty oncology drugs understanding where crizotinib is available, what it costs, and how to access it legally has become a critical part of managing their treatment journey.

Indian generic versions of crizotinib manufactured in India are available at a fraction of that price.

What Is Crizotinib and How Does It Work for Lung Cancer?

Crizotinib is a small-molecule tyrosine kinase inhibitor (TKI) that belongs to the class of targeted cancer therapies.

How Does Crizotinib Work in simple language explain

Think of crizotinib as a lock-and-key mechanism. The ALK fusion protein is the “lock” — a faulty switch that keeps telling cancer cells to grow. Crizotinib is the “key” that fits precisely into that switch and turns it off.

Crizotinib Brand Names in India

Crikzo: Manufactured, marketed by Hetero Labs

Alkros-One: Manufactured and marketed by Intas Pharmaceuticals 

These Indian-manufactured generic versions contain the same active pharmaceutical ingredient (API) crizotinib. They are manufactured in facilities that meet WHO-GMP standards and, in many cases, are USFDA-inspected.

Is Crizotinib a Chemotherapy Drug or a Targeted Therapy?

This is one of the most common questions patients ask. In summary: Crizotinib is not chemotherapy. It is a targeted therapy, a precision medicine approach that works specifically in patients with a confirmed ALK or ROS1 gene rearrangement. This distinction is important because patients on crizotinib generally do not experience the classic chemotherapy side effects like severe hair loss or immune suppression, though crizotinib does have its own side effect profile.

Who May Need Crizotinib? Understanding the Patient Profile

Crizotinib is prescribed primarily to patients who:

• Have been diagnosed with non-small cell lung cancer (NSCLC), typically adenocarcinoma subtype
• Have tested positive for the ALK gene rearrangement or ROS1 rearrangement through molecular diagnostic testing
• Are in the metastatic or advanced stage (Stage IIIB or Stage IV) of the disease
• Are being treated with a first-line targeted therapy (or in some cases, second-line after chemotherapy)

Why Patients Begin Searching Beyond Their Local Healthcare Systems

The cost of branded crizotinib in Western markets is a primary driver of international access inquiries:

For these patients, India the world’s largest supplier of generic pharmaceutical offers a legally accessible alternative through personal import provisions in many countries.

What Are the Most Common Side Effects of Crizotinib 250mg?

Crizotinib is generally well-tolerated compared to chemotherapy, but it does have a recognized side effect profile that patients should be aware of before starting treatment.

Common Side Effects (Experienced by More Than 25% of Patients)

• Visual disturbances — flashes of light, blurred vision, or “floaters,” especially when adjusting from light to dark. Usually mild and does not require stopping treatment.
• Nausea — often manageable; may occur in the first weeks and typically improves
• Diarrhea or constipation — generally Grade 1–2 (mild to moderate); manageable with dietary adjustments
• Vomiting — less common than nausea; anti-emetic medications can help
• Peripheral edema — swelling in the legs, feet, or ankles; usually mild (Grade 1)
• Fatigue — common in the first months; tends to improve as the body adjusts

What Happens When Crizotinib Stops Working?

If your doctor says crizotinib is no longer working, this is not the end of treatment options. ALK-positive NSCLC is one of the most treatment-responsive subtypes of lung cancer, and the sequence of TKI therapies can provide long-term disease control for many patients. Ask your oncologist about molecular re-testing at progression to guide the next treatment choice.

Crizotinib 250mg Price in India vs. Western Market.

The price differential for crizotinib between India and Western markets is among the most significant of any oncology drug. The price of crizotinib in India is very low as compard to the western developed countries.

Why Does Medicine Cost So Much Less in India?

• Patent dynamics: India’s patent laws allow domestic manufacturers to produce generics once the compound’s patent eligibility is assessed
• No R&D cost amortization: Generic manufacturers do not bear the original research, clinical trial, and regulatory submission costs.
• India’s Drug Price Control Order (DPCO): The Indian government regulates prices of essential medicines. Several cancer medicines, including crizotinib, are subject to price control, keeping costs significantly lower than in open markets.

Is Generic Crizotinib from India Safe and Effective?

A generic medicine contains the identical active pharmaceutical ingredient (API) as the originator brand.

Companies like Hetero Labs, Intas pharmaceuticals Laboratories is:

• Manufactured in facilities holding WHO-GMP (Good Manufacturing Practice) certification
• Subject to oversight by India’s Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)
• In many cases, manufactured in facilities that have passed US FDA inspection.

WHO Essential Medicine Status

Crizotinib was added to the WHO Model List of Essential Medicines (EML) a recognition that it is a priority medicine for global health systems. This listing supports the case for affordable generic access in lower- and middle-income countries and is an important indicator of the drug’s clinical significance.

The bottom line: Generic crizotinib from India is not an inferior product. It is the same molecule, manufactured to international standards, at a more accessible price point reflecting a structural difference in pharmaceutical economics, not a difference in quality or efficacy.

Where Can I Buy Generic Crizotinib from India Legally?

International patients may access Indian generic crizotinib through personal importation a provision that exists in many countries allowing patients to import a limited personal-use supply of a prescription medicine. Rules vary significantly by country.

Important disclaimer: Import regulations change, and individual circumstances vary. Patients are strongly advised to verify the current personal import rules in their specific country with a local legal or regulatory professional, or contact the relevant health authority directly before proceeding.

How to Buy Crizotinib from India. What Documents Do You Need?

If you are exploring personal importation of crizotinib from India, the following documentation checklist is typically required:

Patient Documentation:

• Valid prescription from a licensed physician (in your home country)
• Medical records confirming the diagnosis (hospital discharge summary or oncologist’s letter)
• Copy of patient’s passport or national ID (for customs/shipping purposes)

Import Documentation (country-specific):

• Import permit or prior approval (In some countries required)
• Customs declaration form
• Physician’s letter explaining medical necessity

Is It Worth Travelling to India for Crizotinib Treatment?

This is a question many international patients and caregivers consider and the answer depends on several individual factors.

When Medical Travel to India May Make Sense

• Long-term treatment need: Crizotinib is taken continuously (until progression), meaning the monthly cost is an ongoing commitment. Over 12–24 months, the savings on Indian generic pricing compared to US or UAE pricing can amount to hundreds of thousands of dollars.
• Insurance limitations: Patients who are uninsured or whose insurance does not cover crizotinib may find India-based generic access transformative in terms of financial sustainability.
• Access to molecular testing: Major Indian oncology centres (Tata Memorial Hospital in Mumbai, AIIMS Delhi, Apollo, Fortis) offer comprehensive molecular diagnostic testing at a fraction of Western costs useful for patients who need re-testing at progression.

The India Advantage. Why Patients Worldwide Choose India for Generic Oncology Medicines

India is not simply a lower-cost alternative. It is the world’s largest supplier of generic pharmaceutical exports, and this position is built on rigorous manufacturing infrastructure:

• India supplies approximately 20% of global generic medicine exports by volume (Pharmexcil / Pharmaceuticals Export Promotion Council of India)
• Over 500 Indian pharmaceutical manufacturing facilities have passed US FDA inspection
• Indian manufacturers export to the United States, United Kingdom, Europe, Australia, Canada, and regulated markets across the world
• India’s Drug Price Control Order (DPCO) regulates prices of essential medicines, making oncology treatments more accessible to domestic and international patients
• The Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health and Family Welfare is India’s national regulatory body, equivalent in function to the US FDA or UK MHRA

What to Consider Before Travelling

• Regulatory compliance: You will still need a valid prescription from a licensed physician (Indian or home country). Indian oncologists can prescribe, but continuity of care with a home physician is important.
• Personal import logistics: If you are travelling to India to source the medicine and return home, ensure you understand your country’s customs and personal import rules for quantity limits and declaration requirements.
• Quality assurance: Always source medicines from licensed, reputable Indian pharmacies or verified healthcare facilitators.

How Patients Access Crizotinib Through a Licensed Facilitator: The Process

A licensed healthcare facilitator assists patients in navigating the process of accessing medicines through authorized pharmaceutical channels. Here is how the process typically works:

Step 1: Patient Inquiry
A patient or caregiver submits an inquiry with their diagnosis details and the name of the medicine required.

Step 2: Document Verification
The facilitator’s team reviews the submitted prescription and medical records to confirm the diagnosis and prescription authenticity.

Step 3: Source Identification
The medicine is sourced from licensed, authorized Indian pharmaceutical manufacturers or distributors not from unverified third parties.

Step 4: Regulatory Guidance
The facilitator provides country-specific guidance on personal import regulations relevant to the patient’s location (UK, US, UAE, Australia, etc.).

Step 5: Shipping and Documentation
The medicine is shipped with full compliance documentation including commercial invoice, and packing list in accordance with the destination country’s import requirements.

Step 6: Receipt and Continuity
The patient receives the medicine and continues their prescribed treatment plan under their oncologist’s ongoing supervision.

Submit an Inquiry

If you hold a valid prescription for Crizotinib and would like guidance on accessing it through licensed and authorized channels, you may submit an inquiry. Our team will review your request and provide relevant information based on your specific situation and country of residence.

Reach Out for Guidance

If you hold a valid prescription for crizotinib and are seeking information about accessing it through licensed and authorized channels, you may submit an inquiry. Our team will review your request and provide relevant information based on your specific situation, location, and applicable import regulations at no obligation.

A healthcare facilitator with experience in cross-border medicine access can assist with this guidance.

Frquently Asked Questions (FAQs)

What is crizotinib and how does it work for lung cancer?

Crizotinib is a first-generation ALK (anaplastic lymphoma kinase) and ROS1 tyrosine kinase inhibitor (TKI) used to treat non-small cell lung cancer in patients whose tumors carry an ALK or ROS1 gene rearrangement.

Is crizotinib a chemotherapy drug or targeted therapy?

Crizotinib is a targeted therapy, not chemotherapy. Unlike chemotherapy, which broadly kills all rapidly dividing cells (cancerous and healthy), crizotinib is designed to work specifically on tumors with ALK or ROS1 gene rearrangements. It is taken orally (as a capsule, at home), rather than as a hospital infusion, and its side effect profile is generally more manageable than traditional chemotherapy.

Important Disclaimer

The information provided on this page is intended for educational purposes only and does not constitute medical advice. Crizotinib should only be used under the supervision of a qualified oncologist or healthcare professional. Please consult your physician before making any changes to your treatment plan. All regulatory and import information is provided as general guidance only patients should verify applicable rules in their specific country before taking any action.